|
VPS8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.511000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.904600E-01 |
| Normal-vs-Stage2 |
5.643200E-01 |
| Normal-vs-Stage3 |
8.077800E-01 |
| Normal-vs-Stage4 |
5.014600E-01 |
| Stage1-vs-Stage2 |
2.631600E-01 |
| Stage1-vs-Stage3 |
3.482800E-01 |
| Stage1-vs-Stage4 |
1.906780E-01 |
| Stage2-vs-Stage3 |
6.931200E-01 |
| Stage2-vs-Stage4 |
9.924400E-01 |
| Stage3-vs-Stage4 |
6.567800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.482200E-01 |
| Normal-vs-AfricanAmerican |
5.041000E-01 |
| Normal-vs-Asian |
4.149600E-02 |
| Caucasian-vs-AfricanAmerican |
3.398200E-01 |
| Caucasian-vs-Asian |
1.076410E-01 |
| AfricanAmerican-vs-Asian |
3.057400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.437800E-01 |
| Normal-vs-Female |
3.409900E-02 |
| Male-vs-Female |
9.81469999999929E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.639400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.078400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.462600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.750400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.972800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.614400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.203000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.717900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.527800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.317400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.258400E-03 |
| Normal-vs-Grade 2 |
7.665800E-01 |
| Normal-vs-Grade 3 |
8.599600E-01 |
| Normal-vs-Grade 4 |
9.537700E-02 |
| Grade 1-vs-Grade 2 |
1.077750E-03 |
| Grade 1-vs-Grade 3 |
1.620090E-03 |
| Grade 1-vs-Grade 4 |
5.79210000000163E-05 |
| Grade 2-vs-Grade 3 |
8.992800E-01 |
| Grade 2-vs-Grade 4 |
4.293600E-02 |
| Grade 3-vs-Grade 4 |
6.647600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.138200E-01 |
| Normal-vs-ccB subtype |
9.591000E-01 |
| ccA subtype-vs-ccB subtype |
1.671970E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.526800E-01 |
| Normal-vs-N1 |
9.380200E-01 |
| N0-vs-N1 |
6.937800E-01 |
|
|
